At a glance
ClinicalIndex Comparison RecordN/ACompleted· 37 enrolled
Drug / intervention
Trima Accel Auto RBC Collectiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In Vivo 24-Hour Recovery Study of Leukoreduced RBCs Collected on the Trima Accel System Using Non-DEHP Disposable Sets and Stored for 42 Days
In Brief
A clinical study evaluating Trima Accel Auto RBC Collection for Device Validation of In-vivo Performance. Completed, enrolled 37 participants across 2 sites.
Detailed Summary
This is an in vivo 24-hour in-vivo recovery study of leukoreduced red blood cells (RBCs) collected on the Trima Accel System using Non-DEHP disposable sets and stored for 42 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDevice Validation of In-vivo Performance
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20252026
Enrollment StartAug 2024
First PostedSep 2024
Primary CompletionJan 2025
TodayJul 2026
First PostedSep 19, 2024
Enrollment StartAug 26, 2024
Primary CompletionJan 31, 2025
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 1.8 years ago
Interventions
Trima Accel Auto RBC Collectiondevice
This is a non-interventional study, observing the in vivo performance of LR-RBC units derived from Trima Accel Auto RBC collection.